Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between …

ECM de Lange, M Danhof - Clinical pharmacokinetics, 2002 - Springer
In the clinical setting, drug concentrations in cerebrospinal fluid (CSF) are sometimes used
as a surrogate for drug concentrations at the target site within the brain. However, the brain …

Breaking down the blood–brain barrier: signaling a path to cerebral malaria?

S Adams, H Brown, G Turner - Trends in parasitology, 2002 - cell.com
Cerebral malaria is a major killer in the developing world, but we still know very little about
the causes of this disease. How does Plasmodium falciparum cause such a devastating …

Hypoxia‐induced vascular endothelial growth factor expression causes vascular leakage in the brain

HJ Schoch, S Fischer, HH Marti - Brain, 2002 - academic.oup.com
Formation of cerebral oedema caused by vascular leakage is a major problem in various
injuries of the CNS, such as stroke, head injury and high‐altitude illness. A common feature …

High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo

AH Mesiwala, L Farrell, HJ Wenzel… - Ultrasound in medicine …, 2002 - Elsevier
High-intensity focused ultrasound (HIFU) has been shown to generate lesions that destroy
brain tissue while disrupting the blood-brain barrier (BBB) in the periphery of the lesion. BBB …

Targets for pharmacological intervention of endothelial hyperpermeability and barrier function

GP van Nieuw Amerongen, VWM van Hinsbergh - Vascular pharmacology, 2002 - Elsevier
Many diseases share the common feature of vascular leakage, and endothelial barrier
dysfunction is often the underlying cause. The subsequent stages of endothelial barrier …

Cerebral perfusion pressure, and not cerebral blood flow, may be the critical determinant of intracranial injury in preeclampsia: a new hypothesis

MA Belfort, MW Varner, DS Dizon-Townson… - American journal of …, 2002 - Elsevier
Objective: The relationship between cerebral perfusion pressure (CPP) and cerebral blood
flow is unclear in preeclampsia. Our objective was to clarify this issue by comparing normal …

Effects of LF 16-0687 Ms, a bradykinin B2 receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia

S Zausinger, DB Lumenta, D Pruneau… - Brain research, 2002 - Elsevier
Bradykinin, an endogenous nonapeptide produced by activation of the kallikrein–kinin
system, promotes neuronal tissue damage as well as disturbances in blood–brain barrier …

Feline leukemia virus-associated myelopathy in cats

KP Carmichael, D Bienzle… - Veterinary …, 2002 - journals.sagepub.com
Feline leukemia virus (FeLV) infection is associated with distinct neoplastic, hematologic,
and immunosuppressive diseases. Here we report on a novel neurologic syndrome in 16 …

[PDF][PDF] Brain edema in liver failure: basic physiologic principles and management

FS Larsen, J Wendon - Liver transplantation, 2002 - Wiley Online Library
In patients with severe liver failure, brain edema is a frequent and serious complication that
may result in high intracranial pressure and brain damage. This short article focuses on …

Effects of losartan on the blood–brain barrier permeability in long-term nitric oxide blockade-induced hypertensive rats

M Kucuk, M Kaya, R Kalayci, V Cimen, H Kudat… - Life sciences, 2002 - Elsevier
Hypertension is closely associated with vascular endothelial dysfunction. The aim of this
study was to investigate the effects of Angiotensin II (ANG II) receptor antagonist losartan on …